Yuan T

No ORCID on file · 5 papers in corpus · active 2020-2025

Condition tags

  • dysmenorrhea 1
2025
Serum Uric Acid-to-Serum Creatinine Ratio, Thyroid Function, and Gestational Diabetes Mellitus Risk during Early Pregnancy among Chinese Women.
Diabetes, metabolic syndrome and obesity : targets and therapy ·doi:10.2147/dmso.s486695

ObjectiveThis study aimed to explore the relationship between serum uric acid-to-serum creatinine (UA:SCr) ratio and thyroid function within the normal range and in gestational diabetes mellitus (GDM) during early pregnancy in Chinese women…

2024
An expanded database and analytical toolkit for identifying bacterial virulence factors and their associations with chronic diseases.
Nature communications ·doi:10.1038/s41467-024-51864-y

Virulence factor genes (VFGs) play pivotal roles in bacterial infections and have been identified within the human gut microbiota. However, their involvement in chronic diseases remains poorly understood. Here, we establish an expanded VFG …

2021
Abdominal and Pelvic Pain: Current Challenges and Future Opportunities.
Frontiers in pain research (Lausanne, Switzerland) ·doi:10.3389/fpain.2021.634804
2021
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives.
Signal transduction and targeted therapy ·doi:10.1038/s41392-021-00572-w

Due to the advantages in efficacy and safety compared with traditional chemotherapy drugs, targeted therapeutic drugs have become mainstream cancer treatments. Since the first tyrosine kinase inhibitor imatinib was approved to enter the mar…

2020
Effectiveness and Safety of Acupuncture and Moxibustion for Primary Dysmenorrhea: An Overview of Systematic Reviews and Meta-Analyses.
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2020/8306165

BackgroundAcupuncture and moxibustion have been accepted as treatment options for primary dysmenorrhea (PD). So far, several systematic reviews (SRs) and meta-analyses (MAs) have reported on the efficacy and safety of acupuncture and moxibu…